EPIQ Rush
Natural health product licensed in Canada
- Licence holder
- Iovate Health Sciences International Inc.
- NPN or DIN-HM
- 80053289
- Status
- Inactive licence
- Licence date
- 21 August 2014
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,3,7-Triméthylxanthine Source : Caféine | 137.5 mg | Not calculated |
| Beta vulgaris Source : Racine | 50 mg | Not calculated |
| Camellia sinensis Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 400 mg Potency : 12.5 % caffeine | 100 mg | Not calculated |
| L-arginine Source : L-arginine | 1.44 g | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 500 mg | Not calculated |
| 4-(4-hydroxyphényl)-2-butanone | 60 mg | Not calculated |
| L-théanine Source : L-Théanine | 25 mg | Not calculated |
| Ophiocordyceps sinensis Source : Mycelia | 25 mg | Not calculated |
| Cocos nucifera Source : Fruit | 10 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 25 % Epigallocaterchin 3-gallate | Not specified | Not calculated |
Non-medicinal ingredients
Acide DL-malique, Sucralose, Dioxyde de silicium, Acesulfame Potassium, Saveur de fraise, Maltodextrine, Saveur, Watermelon flavour, Concentré de jus de betterave
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance and to enhance motor performance. Provides an essential amino acid which aids in protein synthesis. To help promote muscle pumps increased blood flow and circulation, and transporting important nutrients to working muscles.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053289
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.